{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:14:13Z","timestamp":1791332053325,"version":"4.3.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3696-x","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T08:03:02Z","timestamp":1547712182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-8762","authenticated-orcid":false,"given":"Amon","family":"Sabasaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Mwambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Somi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angella","family":"Ramadhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mahande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"3696_CR1","doi-asserted-by":"publisher","unstructured":"Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002;16(1):75\u201383 \n                    https:\/\/doi.org\/10.1097\/00002030-200201040-00010PMID:11741165\n                    \n                  .","DOI":"10.1097\/00002030-200201040-00010PMID:11741165"},{"key":"3696_CR2","unstructured":"World Health Organization. Global tuberculosis report 2015: World Health Organization; 2015."},{"key":"3696_CR3","doi-asserted-by":"crossref","unstructured":"Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, Kestens L, Colebunders R. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clin Dev Immunol 2010 Dec;2011.","DOI":"10.1155\/2011\/758350"},{"key":"3696_CR4","unstructured":"Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management Indian J Med Res 2005;121(4):550\u2013567. PMID:15817963."},{"key":"3696_CR5","volume-title":"InWHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders. In: InWHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders; 2012."},{"key":"3696_CR6","doi-asserted-by":"crossref","unstructured":"Denholm JT, McBryde ES, Eisen DP, Penington JS, Chen C, Street AC. Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study. Drug Healthc Patient Saf 2014;6:145\u2013149. https:\/\/doi.org\/10.2147\/DHPS.S68837 PMID:25364275.","DOI":"10.2147\/DHPS.S68837"},{"issue":"5","key":"3696_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/QAI.0000000000000219","volume":"66","author":"DW Dowdy","year":"2014","unstructured":"Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. J acquired immune deficiency syndromes (1999). 2014;66(5):552.","journal-title":"J acquired immune deficiency syndromes (1999)"},{"key":"3696_CR8","unstructured":"Teferi T, Iyaloo J, Kalibbala M, Makai M, Hango JN, Nkongolo OT. Effect of primary isoniazid preventive therapy on tuberculosis incidence rate among HIV-infected adults enrolled in HIV care in northern Namibia 2012: a retrospective cohort study. AIDS 2012. Presented at the - 19th International AIDS Conference, 2012: Abstract WEPE066. 22\u201327 July 2012. Washington, D.C."},{"key":"3696_CR9","volume-title":"World Health Organization","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Global tuberculosis report 2014. In: World Health Organization; 2014."},{"key":"3696_CR10","unstructured":"Ramadhani A, Josiah RM, Rwebembera A, Msuya EL, Swai R, Urassa P, Kalluvya S, Omari S, Kaganda J, Kibao A. Schimana W. National guidelines for the management of HIV and AIDS."},{"key":"3696_CR11","volume-title":"6th ed","author":"National Tuberculosis and Leprosy Programme (NTLP)","year":"2013","unstructured":"National Tuberculosis and Leprosy Programme (NTLP). Manual for the management of tuberculosis and leprosy. In: 6th ed; 2013."},{"key":"3696_CR12","unstructured":"Zanzibar AIDS Commission. Tanzania HIV\/AIDS and malaria indicator survey 2011\u201312."},{"issue":"11","key":"3696_CR13","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","volume":"29","author":"E Liu","year":"2015","unstructured":"Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, Chalamilla G, Sudfeld CR, Hertzmark E, Fawzi WW. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral Therapy. AIDS (London, England). 2015 Jul;29(11):1391\u20139.","journal-title":"AIDS (London, England)"},{"key":"3696_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12879-015-0812-4","volume":"15","author":"L Nakiyingi","year":"2015","unstructured":"Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, et al. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. BMC Infect Dis. 2015 Feb;15:62.","journal-title":"BMC Infect Dis"},{"key":"3696_CR15","doi-asserted-by":"crossref","unstructured":"Assebe LF, Reda HL, Wubeneh AD, Lerebo WT, Lambert SM. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health. 2015;15(1):346.","DOI":"10.1186\/s12889-015-1719-0"},{"key":"3696_CR16","doi-asserted-by":"crossref","unstructured":"Yirdaw KD, Jerene D, Gashu Z, Edginton ME, Kumar AMV, Letamo Y, et al. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PLoS One. 2014;9(8).","DOI":"10.1371\/journal.pone.0104557"},{"issue":"3","key":"3696_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7196\/SAMJ.7689","volume":"104","author":"GJ Churchyard","year":"2014","unstructured":"Churchyard GJ, Mametja LD, Mvusi L, Ndjek N, Hesseling AC, Reid A, et al. Tuberculosis control in South Africa: successes, challenges and recommendations. S Afr Med J. 2014 Jan 1;104(3):244\u20138.","journal-title":"S Afr Med J"},{"issue":"1","key":"3696_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12879-016-2109-7","volume":"17","author":"M Semu","year":"2017","unstructured":"Semu M, Fenta TG, Medhin G, Assefa D. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV\/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study. BMC Infect Dis. 2017 Jan;17(1):5.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"3696_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","volume":"23","author":"JE Golub","year":"2009","unstructured":"Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, Struthers H, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS Lond Engl. 2009 Mar;23(5):631\u20136.","journal-title":"AIDS Lond Engl"},{"issue":"9","key":"3696_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","volume":"373","author":"Temprano ANRS 12136 Study Group","year":"2015","unstructured":"Temprano ANRS 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015 Aug;373(9):808\u201322.","journal-title":"N Engl J Med"},{"issue":"10","key":"3696_CR21","first-page":"1105","volume":"9","author":"PA Venkatesh","year":"2005","unstructured":"Venkatesh PA, Bosch RJ, McIntosh K, Mugusi F, Msamanga G, Fawzi WW. Predictors of incident tuberculosis among HIV-1-infected women in Tanzania. The International Journal of Tuberculosis and Lung Disease. 2005 Oct;9(10):1105\u201311.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"4","key":"3696_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","volume":"56","author":"A Rie Van","year":"2011","unstructured":"Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr. 2011 Apr;56(4):349\u201355.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3696_CR23","doi-asserted-by":"publisher","unstructured":"Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, Rawizza HE, Tchetgen Tchetgen E, Kanki PJ. Tuberculosis incidence and risk factors among human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy in a large HIV program in Nigeria. In Open forum infectious diseases 2015 Dec 1 (Vol. 2, no. 4). Oxford University Press.\u00a0\n                    https:\/\/doi.org\/10.1093\/ofid\/ofv154","DOI":"10.1093\/ofid\/ofv154"},{"key":"3696_CR24","doi-asserted-by":"publisher","unstructured":"Rangaka MX, Wilkinson RJ, Boulle A, Glynn JR, Fielding K, van Cutsem G, et al. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet. 2014;384(9944):682\u201390. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(14)60162-8\n                    \n                  . \n                    24835842\n                    \n                  .","DOI":"10.1016\/S0140-6736(14)60162-8"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3696-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T19:07:11Z","timestamp":1579201631000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3696-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3696"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3696-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"14 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Kilimanjaro Christian Medical University College (KCMUCo). The need for informed consent was deemed unnecessary since we used secondary data which did not have any identifier and it was unlinked from the database. Permission to use CTC data was sought from the MOHCDGEC through the National Aids Control Program (NACP).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The permission to publish the data was obtained from the NACP after being fully informed about the objectives and findings of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"62"}}